Fiche centre
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi — China
Essais liés4clinical trials
VilleÜrümqilocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07575672
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| SEEG RF-TC | Épilepsie | Non applicable | NCT07923058 | SEEG-DRE — Clinical Trial of SEEG for Drug-resistant Epilepsy | NOT_YET_RECRUITING |
| BI 690517 | Maladie rénale chronique | Phase 3 | NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) | ACTIVE_NOT_RECRUITING |
| Finerenone | Insuffisance cardiaque | Phase 3 | NCT07575672 | FINE-VALUE — Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure | RECRUITING |
| obinutuzumab (RO5072759) | Lupus | Phase 3 | NCT07767188 | A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the Active Lupus Nephritis Patients (INITIAL Trial) | NOT_YET_RECRUITING |